Abstract
Aims
To evaluate the association between diabetes mellitus (DM) and risk of seizures in a well-defined elderly population.
Methods
The administrative databases of the Lombardy region (a 10 million population area in Northern Italy) were used to identify persons aged 65 years or older with DM (defined by prescription of antidiabetic drugs and/or through ICD-9 CM code and/or exemption code for diabetes) during the year 2002. Seizure-free DM subjects were followed until 2012 in search of individuals with incident seizures (identified through ICD-9 CM codes for epilepsy/seizures or ATC codes for antiepileptic drugs associated with the prescription of an electroencephalogram). To adjust for confounding, comorbidities having epileptogenic potential were also identified through the ICD-9 CM codes.
Results
The population at risk included 1,494,071 persons. Of these, 136,941 seizure-free patients had DM. At the end of follow-up, the cumulative time-dependent incidence of seizures was 3.0% in DM patients and 1.9% in No-diabetic individuals (hazard ratio, HR 1.47; 95% confidence interval, 1.41–1.53, adjusted for age classes, sex, comorbidities and number of hospital admission). The HR was unchanged in patients with no history of stroke. The cumulative incidence of seizures after DM increased with the number of hospital admissions.
Conclusions
DM is an independent risk factor for seizures in elderly individuals. In diabetic patients, the risk of seizures increases with the number of comorbidities, supporting the role of vascular disease as a cause of seizures.
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00592-017-1011-0/MediaObjects/592_2017_1011_Fig1_HTML.gif)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00592-017-1011-0/MediaObjects/592_2017_1011_Fig2_HTML.gif)
Similar content being viewed by others
References
Yun C, Xuefeng W (2013) Association between seizures and diabetes mellitus: a comprehensive review of literature. Curr Diabetes Rev 9:350–354
McCorry D, Nicolson A, Smith D et al (2006) An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 59:204–206
Schober E, Otto KP, Dost A et al (2012) Association of epilepsy and type 1 diabetes mellitus in children and adolescents: is there an increased risk for diabetic ketoacidosis? J Pediatr 160:662–666
Chou IC, Wang CH, Lin WD et al (2016) Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study. Diabetologia 59:1196–1203
O’Connell MA, Harvey AS, Mackay MT et al (2008) Does epilepsy occur more frequently in children with type 1 diabetes? J Paediatr Child Health 44:586–589
Adelöw C, Andersson T, Ahlbom A et al (2011) Prior hospitalization for stroke, diabetes, myocardial infarction, and subsequent risk of unprovoked seizures. Epilepsia 52:301–307
Huang CW, Tsai JJ, Ou HY et al (2008) Diabetic hyperglycemia is associated with the severity of epileptic seizures in adults. Epilepsy Res 79:71–77
Forsgren L, Beghi E, Oun A et al (2005) The epidemiology of epilepsy in Europe—a systematic review. Eur J Neurol 12:245–253
Monesi L, Baviera M, Marzona I et al (2012) Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study. Diabet Med 29:385–392
Franchi C, Giussani G, Messina P et al (2013) Validation of health care administrative data for the diagnosis of epilepsy. J Epidemiol Community Health 67:1019–1024
Keezer MR, Novy J, Sander JW (2015) Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: prevalence and clinical characteristics. Epilepsy Res 115:55–57
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653
Holman RR, Paul SK, Bethel MA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589
Gaede P, Lund-Andersen H, Parving HH et al (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591
Umemura T, Kawamura T, Hotta N (2017) Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: a possible link between cerebral and retinal microvascular abnormalities. J Diabetes Investig 8(2):134–148
Pugh MJ, Knoefel JE, Mortensen EM et al (2009) New-onset epilepsy risk factors in older veterans. J Am Geriatr Soc 57:237–242
Li X, Breteler MM, de Bruyne MC et al (1997) Vascular determinants of epilepsy: the Rotterdam Study. Epilepsia 38:1216–1220
Nabbout R (2012) Autoimmune and inflammatory epilepsies. Epilepsia 53(Suppl 4):58–62
Pociot F, Lernmark Å (2016) Genetic risk factors for type 1 diabetes. Lancet 387:2331–2339
Itariu BK, Stulnig TM (2014) Autoimmune aspects of type 2 diabetes mellitus—a mini-review. Gerontology 60:189–196
Maheandiran M, Mylvaganam S, Wu C et al (2013) Severe hypoglycemia in a juvenile diabetic rat model: presence and severity of seizures are associated with mortality. PLoS One 8:e83168. doi:10.1371/journal.pone.0083168
Schwechter EM, Velísková J, Velísek L (2003) Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 53:91–101
Kirchner A, Velísková J, Velísek L (2006) Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur J Neurosci 23:1512–1522
Soltész G, Acsádi G (1989) Association between diabetes, severe hypoglycaemia, and electroencephalographic abnormalities. Arch Dis Child 64:992–996
Acknowledgements
We thank Igor Monti from IRCCS—Istituto di Ricerche Farmacologiche Mario Negri, Simone Schiatti and Giovanna Rigotti from Lombardia Informatica S.p.A, Alfredo Bevilacqua from SANTER Reply S.p.A, and Fiorenza Clerici from IRCCS—Istituto di Ricerche Farmacologiche Mario Negri, who kindly assisted us with data collection and secretarial activities.
Author information
Authors and Affiliations
Contributions
Guarantor’s name: All authors take responsibility for the contents of the article. BE, BM, RMC and TM took part in study concept and design, and interpretation of data. FI, BA and ML performed acquisition of data. VT and TM carried out analysis of data. BE, BM and RMC drafted the manuscript. All authors participated in critical revision of the manuscript for important intellectual content.
Corresponding author
Ethics declarations
Conflict of interest
Ettore Beghi received personal fees from Viropharma to participate in an Advisory Board, research grants from UCB-Pharma, EISAI, Shire, the Italian Drug Agency (AIFA), the Italian Ministry of Health, the American ALS Association and the Borgonovo Foundation. The other authors have nothing to declare.
Funding
No funding has been provided for this work.
Human and animal rights
In Italy, approval from an ethics committee is not required to analyze encrypted administrative data according to the National law.
Informed consent
In Italy, informed consent is not required to analyze encrypted administrative data according to the National law.
Additional information
Managed by Massimo Federici.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Baviera, M., Roncaglioni, M.C., Tettamanti, M. et al. Diabetes mellitus: a risk factor for seizures in the elderly—a population-based study. Acta Diabetol 54, 863–870 (2017). https://doi.org/10.1007/s00592-017-1011-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-017-1011-0